Stephens Consulting, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,680
-20.4%
1,0000.0%0.00%0.0%
Q2 2023$8,390
-15.5%
1,0000.0%0.00%
-50.0%
Q1 2023$9,930
+42.7%
1,0000.0%0.01%
+20.0%
Q4 2022$6,960
+30.3%
1,0000.0%0.01%0.0%
Q3 2022$5,340
+33.8%
1,0000.0%0.01%
+66.7%
Q2 2022$3,990
-10.2%
1,0000.0%0.00%
-25.0%
Q1 2022$4,445
-44.4%
1,000
-50.0%
0.00%
-42.9%
Q4 2021$8,0002,0000.01%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders